Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ 1 347 207 4849

Related Posts

Title Image

Blog

A Japan big fund needs a breakthrough biotech company for Japan Stroke market

A Japan big fund needs a breakthrough biotech company for Japan Stroke market. 2,000,000 Japanese suffer from stroke injury and loss of function. Our Omgeneum will be supported in Japan by big fund to complete IPO. Sanbio (Japan competition ) has a market capitalization of almost 2 billion because they failed phase 2. Clinical trial for stroke. The market capitalization was 6 Billion USD . We have a much better technology breakthrough

No Comments
Post a Comment
Name
E-mail
Website